Johnson & Johnson's most recent trend suggests a bearish bias. One trading opportunity on Johnson & Johnson is a Bear Call Spread using a strike $170.00 short call and a strike $180.00 long call offers a potential 13.51% return on risk over the next 28 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $170.00 by expiration. The full premium credit of $1.19 would be kept by the premium seller. The risk of $8.81 would be incurred if the stock rose above the $180.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Johnson & Johnson is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Johnson & Johnson is bearish.
The RSI indicator is at 21.27 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Johnson & Johnson
Moderna President details new clinical data on COVID-19 vaccine
Wed, 15 Sep 2021 21:00:05 +0000
Moderna Presdient Stephen Hoge joins Yahoo Finance to discuss the latest infomration about Moderna's COVID-19 vaccine.
Biden meets with CEOs, business leaders on vaccine mandates
Wed, 15 Sep 2021 18:40:24 +0000
Yahoo Finance’s Jessica Smith reports what to expect from Biden’s meeting on vaccine mandates with top business executives.
Doctor on Biden’s vaccine mandate: ’Extraordinary times call for extraordinary measures’
Wed, 15 Sep 2021 17:51:59 +0000
Dr. James Simmons, Hospitalist Nurse Practitioner in Los Angeles, CA, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
Why Moderna stock has been in rally mode this month
Wed, 15 Sep 2021 16:51:16 +0000
Hartaj Singh, Oppenheimer Analyst joins the Yahoo Finance Live panel with the latest on Moderna stock.
Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now
Wed, 15 Sep 2021 15:45:03 +0000
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.
Also on Market Tamer…
Follow Us on Facebook